| Revenue growth | Robust 36% YoY revenue growth driven by new facility ramp-ups. |
|---|---|
| Margins | EBITDA margins stable at 24.2%; adjusted margins reach 28.5%. |
| Demand visibility | Strong demand in NCR; ARPOB rising via super-specialty and international patients. |
| Management confidence | Balanced and optimistic, highlighting successful integration of recent acquisitions. |
Growth
Consolidated revenue grew 36% YoY; EBITDA increased 30% with new facilities in Noida and Faridabad scaling faster than expected.
Outlook
Targeting 5,000 beds within three years; FY27 revenue growth guided to surpass 36% YoY.
Risks
Expansion-related debt costs increased interest expenses; ongoing income tax scrutiny remains under resolution.
Earnings Call filed with NSE, NSE: YATHARTH. Summary written with AI assistance from the document.
Yatharth Hospital & Trauma Care Services Ltd: key numbers
- Share price
- ₹1,046.60
- Market cap
- ₹10,084 Cr
- Revenue (annual)
- ₹1,207 Cr
- Net profit (annual)
- ₹175.4 Cr
- P/E (TTM)
- 52.9×Sector 54.5×
- Promoter holding
- 55.80%+0.00% QoQ
- FII holding
- 7.05%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Yatharth Hospital & Trauma Care Services Ltd
All →Yatharth Hospital & Trauma Care Services Preferential Issue
Yatharth Hospital received CCI approval for its proposed ₹3,150 Crore preferential issue to Rasmalai Limited (24.87% stake). This clears a key regulatory hurdle for the capital raise.
- Value
- ₹3,150 Cr
Yatharth Hospital & Trauma Care Services Earnings Call Transcript: Key Takeaways
Yatharth delivered record performance driven by newer acquisitions turning EBITDA positive and a strategic 3,150 Cr Advent partnership to double bed capacity.
- Call
- Guides 30% growth
Yatharth Hospital & Trauma Care Services Investor Presentation: Key Takeaways
Q2 FY27 revenue Rs 4,314 mn (+52% YoY), EBITDA Rs 1,020 mn (23.6% margin), PAT Rs 485 mn (+17% YoY). Advent Rs 3,150 cr primary infusion awaits approvals.
Yatharth Hospital & Trauma Care Services Results Update
Yatharth Hospitals reported a 52% YoY revenue growth to Rs 4,314 million for Q2 FY27. The company also announced a Rs 3,150 crore strategic investment from Advent International.
- Value
- ₹431.4 Cr
- hospital beds
- 3255.0 beds
Yatharth Hospital & Trauma Care Services Q2 FY27 Results: Net Profit ₹48.5 Cr, Up 17.4% YoY
Yatharth Hospital & Trauma Care Services Ltd reported revenue from operations of ₹431.4 Cr (+52.4% YoY) and net profit of ₹48.5 Cr (+17.4% YoY) for Q2 FY27.
- Key figure
- Net profit ₹48.5 Cr · +17.4% YoY
Yatharth Hospital & Trauma Care Services Board Meeting Date
Yatharth Hospital intimated that its Board will meet on 3 Nov 2026 to consider Q2 FY27 unaudited results. No financial figures or decisions are reported in this advance notice.